.svg.png){kind=small}
.svg){kind=small}
Stocks to Invest in
Lexaria Bioscience is revolutionizing drug delivery with its DehydraTECH™ technology, enhancing oral absorption of medications and enabling drugs to cross the blood-brain barrier more effectively. This innovation could replace injections, especially for GLP-1 anti-obesity drugs, promising better patient experiences with fewer side effects and improved blood sugar control. With 39 patents granted and more pending globally, Lexaria is leading the charge in non-invasive drug delivery, making significant strides in patient care and treatment methodologies.
More human study results for Lexaria's patented technology are coming soon.
For more information on Lexaria Bioscience Corp. (NASDAQ: LEXX) please click on the request investor info button.
.png){kind=small}
